Journal
JOURNAL OF NEUROSCIENCE
Volume 26, Issue 37, Pages 9462-9470Publisher
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.2625-06.2006
Keywords
axon formation; axonogenesis; c-Jun N-terminal kinase; JNK; ATF-2; JIP-1; axon; SP600125
Categories
Funding
- NEI NIH HHS [R01 EY005285, EY005285] Funding Source: Medline
- NICHD NIH HHS [R01 HD039884, HD039884] Funding Source: Medline
- NINDS NIH HHS [NS17112, R01 NS017112] Funding Source: Medline
Ask authors/readers for more resources
A critical transition in neuron development is formation of the axon, which establishes the polarized structure of the neuron that underlies its entire input and output capabilities. The morphological events that occur during axonogenesis have long been known, yet the molecular determinants underlying axonogenesis remain poorly understood. We demonstrate here that axonogenesis requires activated c-Jun N-terminal kinase (JNK). JNK is expressed throughout the neuron, but its phosphorylated, activated form is highly enriched in the axon. In young axons, activated JNK forms a proximodistal gradient of increasing intensity, beginning at about the point where the axon exceeds the lengths of the other neurites (minor processes). Treatment with SP600125, a specific inhibitor of JNK, reversibly inhibits axonogenesis but does not prevent the formation of minor processes or their differentiation into dendrites (based on their immunostaining with marker proteins). Expression of a dominant-negative construct against JNK similarly prevents axonogenesis. Investigation of JNK targets revealed that activating transcription factor-2 is phosphorylated under normal conditions in neurons, and its phosphorylation is significantly attenuated after JNK inhibition. These results demonstrate that activated JNK is required for axonogenesis but not formation of minor processes or development of dendrites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available